Clinical and electrocardiographic predictors of recurrent atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 23, Issue 3, 2000, Pages 352-358

  Dilaveris, Polychronis E ^a,b   Gialafos, Elias J ^a   Andrikopoulos, George K ^a   Richter, Dimitris J ^a   Papanikolaou, Vasilios ^a   Poralis, Konstantinos ^a   Gialafos, John E ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Age; P wave duration; Paroxysmal atrial fibrillation; Recurrence

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DISEASE MARKER; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; P WAVE; RECURRENT DISEASE; SINUS RHYTHM;

EID: 0034116208     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2000.tb06761.x     Document Type: Article

References (41)

1. 1. Kannel WB, Abbott RD, Savage DD, et al. Epidemiological features of chronic atrial fibrillation: The Framingham Study. N Engl J Med 1982; 306:1018-1022.
2. 2. Alpert JS, Petersen P, Godtfredsen J. Atrial fibrillation: Natural history, complications, and management. Annu Rev Med 1988; 39: 41-52.
3. 3. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983; 106:389-396.
4. 4. Lip GYH. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? Lancet 1997; 349:1565-1566.
5. 5. Bennett D. Atrial fibrillation. Eur Heart J 1984; 5(Suppl. A):89-93.
6. 6. Cobbe SM. Using the right drug. A treatment algorithm for atrial fibrillation. Eur Heart J 1997; 18(Suppl.):C33-C39.
7. 7. Flaker GC, Fletcher KA, Rothbart RM, et al. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol 1995; 76:355-358.
8. 8. Turitto G, Bandarizadeh B, Salciccioli L, et al. Risk stratification for recurrent tachyarrhythmias in patients with paroxysmal atrial fibrillation and flutter: Role of signal averaged electrocardiogram and echocardiography. PACE 1998; 21:197-201.
9. 9. Suttorp MJ, Kingma H, Koomen EM, et al. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 1993; 71:710-713.
10. 10. Brodsky MA, Allen BJ, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63:1065-1068.
11. 11. Dittrich HC, Erickson JS, Schneiderman T, et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63:193-197.
12. 12. Ewy GA, Ulfers L, Hager WD, et al. Response of atrial fibrillation to therapy, role of etiology and left atrial size. J Electrocardiol 1980; 13:119-124.
13. 13. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53:273-279.
14. 14. Michelucci A, Padeletti L, Chelucci A, et al. Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation. PACE 1996; 19:758-767.
15. 15. Kerr CR, Boone J, Connolly SJ, et al. The Canadian registry of atrial fibrillation: A noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. Am J Cardiol 1998; 82: 82N-85N.
16. 16. Montereggi A, Marconi P, Olivotto I, et al. Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism. Am J Cardiol 1996; 77:266-269.
17. 17. Guidera S, Steinberg J. The signal-averaged P wave duration: A rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993; 21:1645-1651.
18. 18. Falk RH, Pollak A. Signal-averaged P wave duration and atrial fibrillation. J Am Coll Cardiol 1994; 23:548-551.
19. 19. Fukunami M, Yamada T, Ohmori M, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991;83:162-169.
20. 20. Stafford PJ, Robinson D, Vincent R. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation Br Heart J 1995; 74:413-418.
21. 21. Seifert M, Josephson ME. P-wave signal averaging. High tech or an expensive alternative to the standard EGG? Circulation 1993; 88:2980-2982.
22. 22. Dilaveris P, Gialafos E, Sideris S, et al. Simple electrocardiographic markers for the prediction of idiopathic paroxysmal atrial fibrillation. (abstract) PACE 1997; 20(Pt II):1098.
23. 23. Dilaveris PE, Gialafos EJ, Sideris S, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998; 135:733-738.
24. 24. Gialafos JE, Dilaveris PE, Gialafos EJ, et al. P-wave dispersion: A valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvas Electrocardiol 1999; 4:39-45.
25. 25. Alt E, Ammer R, Lehmann G, et al. Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 1997; 134:419-425.
26. 26. Van Bemmel JH, Kors JA, Van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods Inf Med 1990; 29:346-353.
27. 27. Van Bemmel JH, Zywietz C, Kors JA. Signal analysis for ECG interpretation. Methods Inf Med. 1990; 29:317-329.
28. 28. Dilaveris PE, Andrikopoulos GK, Metaxas G, et al. Effects of ischemia on P wave dispersion and maximum P wave duration during spontaneous anginal episodes. PACE 1999; 22:1640-1647.
29. 29. Buxton AE, Josephson ME. The role of P wave duration as a predictor of postoperative atrial arrhythmias. Chest 1981; 80:68-73.
30. 30. Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol 1991; 68:751-755.
31. 31. Klein M, Evans SJL, Blumberg S, et al. Use of P-wave-triggered, P-wave signal-averaged electrocardiogram to predict atrial fibrillation after coronary artery bypass surgery. Am Heart J 1995; 129: 895-901.
32. 32. Kloter Weber U, Osswald S, Huber M, et al. Selective versus nonselective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: Is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J 1998; 19:794-800.
33. 33. Coumel P. Electrophysiology, pacing, and arrhythmia. Clinical approach to paroxysmal atrial fibrillation. Clin Cardiol 1990; 13: 209-212.
34. 34. Wang J, Bourne GW, Wang Z, et al. Comparative mechanisms of antiarrhythmic drug action on experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation 1993; 88:1030-1044.
35. 35. Allessie MA, Wijffels MC, Dorland R. Mechanisms of pharmacologic cardioversion of atrial fibrillation by Class I drugs. J Cardiovasc Electrophysiol 1998; 9(Suppl.):S69-77.
36. 36. Prystowsky EN, Katz A. Atrial fibrillation. In EJ Topol (ed.): Textbook of Cardiovascular Medicine. Philadelphia, Lippincott-Raven Publishers, 1998, pp. 1661-1693.
37. 37. Dittrich HC, Pearce LA, Asinger RW, et al. Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Am Heart J 1999; 137:494-499.
38. 38. Josephson ME, Kastor JA, Morganroth J. Electrocardiographic left atrial enlargement: Electrophysiologic, echocardiographic and hemodynamic correlates. Am J Cardiol 1977; 39:967-971.
39. 39. Frost L, Lund B, Pilegaard H, et al. Re-evaluation of the role of P-wave duration and morphology as predictors of atrial fibrillation and flutter after coronary artery bypass surgery. Eur Heart J 1996; 17:1065-1071.
40. 40. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia, II: The role of nonuniform recovery of excitability in the occurrence of unidirectional block as studied with multiple microelectrodes. Circ Res 1976; 39:168-177.
41. 41. Gencel L, Poquet F, Gosse P, et al. Correlation of signal-averaged P wave with electrophysiological testing for atrial vulnerability in strokes of unexplained etiology. PACE 1994; 17(Pt.II):2118-2124.